Similar Posts
Frequently Asked Questions About the Proposed New Methadone Regulations
Substance Abuse Mental Health Services Administration FAQ July 22, 1999 1. Why is the Department of Health and Human Services (HHS) moving away from direct federal inspection by the FDA to surveys by accreditation organizations? HHS is proposing to move to an accreditation system to improve the quality of treatment for patients. While FDA regulation…
American Association for the Treatment of Opioid Dependence October 16-20, 2004 – Orlando, Florida
20th Anniversary National Methadone Conference American Association for the Treatment of Opioid Dependence October 16-20, 2004 – Orlando, Florida Saturday: October 16, 2004 Preconference Events The Certified Methadone Advocate Course Sunday: October 17, 2004 Special Meeting Patient Support Community and Education Project Meeting Monday: October 18, 2004 NAMA Organizational Meeting Wednesday: October 20, 2004 Workshop…
The Methadone Maintained Patient and the Treatment of Pain by J. Thomas Payte, Elizabeth Khuri, Herman Joseph and Joycelyn Woods
Next In Series Next Page The Opiate-Dependent Person and Pain Methadone patients who are hospitalized with acute or chronic pain conditions are at high risk for receiving inadequate medication for relief of pain. There are several major reasons for this. First, many health professionals incorrectly believe that methadone patients will obtain pain relief from…
THESE ARE THE OLD REGULATIONS
CFR 291.501 Methadone in the Maintenance Treatment of Narcotic Addicts Admission Requirements Take Homes Take Home Exceptions (a) The Food and Drug Administration and the Drug Enforcement Administration recognize that the investigational use of methadone requiring the prolonged maintenance of narcotic dependence as part of a total treatment effort has shown promise in the management…
Comments by Andrew Byrne …Office-Based Treatment of Opiate Addiction with a Sublingual-Tabl eFormulation of Buprenorphine and Naloxon
Dr Andrew Byrne, Medical Practitioner, Drug and Alcohol New South Wales, Australia Email – [email protected] September 23, 2003 This study randomised consenting heroin dependent subjects to receive one month’s treatment with (i) buprenorphine, (ii) buprenorphine/naloxone or (iii) placebo. For a further 11 months, surviving (sic) patients were followed in an open-label manner for primary outcome…
Press Release – July 25, 1998
National Alliance of Methadone Advocates Inc. FOR IMMEDIATE RELEASE July 25, 1998 435 Second Avenue, New York, NY 10010 Contact: Joycelyn Woods Policy Statement (212) 595-6262 Press Release Mayor Guilianis Announcement About Plan to Close Methadone Programs in New York City Uses a Misunderstood Drug Treatment to Promote Celebrity at the…